share_log

Redhill Biopharma | EFFECT: Others

Redhill Biopharma | EFFECT: Others

Redhill Biopharma | EFFECT：其他
美股sec公告 ·  04/23 18:04
牛牛AI助理已提取核心訊息
RedHill Biopharma Ltd., a biopharmaceutical company, has received a Notice of Effectiveness from the United States Securities and Exchange Commission (SEC) on April 22, 2024. The notice indicates that the company's submission, identified by Accession Number 0001558370-24-005273 and Submission Type POS AM, has been officially accepted by the SEC. The effectiveness of the submission is a significant regulatory milestone for RedHill Biopharma, which is listed under CIK number 0001553846 and file number 333-276979.
RedHill Biopharma Ltd., a biopharmaceutical company, has received a Notice of Effectiveness from the United States Securities and Exchange Commission (SEC) on April 22, 2024. The notice indicates that the company's submission, identified by Accession Number 0001558370-24-005273 and Submission Type POS AM, has been officially accepted by the SEC. The effectiveness of the submission is a significant regulatory milestone for RedHill Biopharma, which is listed under CIK number 0001553846 and file number 333-276979.
生物製藥公司RedHill Biopharma Ltd. 已於2024年4月22日收到美國證券交易委員會（SEC）的生效通知。該通知指出，該公司提交的材料已被美國證券交易委員會正式接受，其註冊號爲0001558370-24-005273，提交類型爲POS AM。該提交的有效性是RedHill Biopharma的重要監管里程碑，該公司在CIK下上市，編號爲0001553846，文件編號爲333-276979。
生物製藥公司RedHill Biopharma Ltd. 已於2024年4月22日收到美國證券交易委員會（SEC）的生效通知。該通知指出，該公司提交的材料已被美國證券交易委員會正式接受，其註冊號爲0001558370-24-005273，提交類型爲POS AM。該提交的有效性是RedHill Biopharma的重要監管里程碑，該公司在CIK下上市，編號爲0001553846，文件編號爲333-276979。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。